CAMMAROTA, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 300
EU - Europa 130
AS - Asia 119
AF - Africa 4
Totale 553
Nazione #
US - Stati Uniti d'America 292
SG - Singapore 61
CN - Cina 54
IT - Italia 38
NL - Olanda 36
IE - Irlanda 18
FI - Finlandia 14
CA - Canada 8
SE - Svezia 8
GB - Regno Unito 5
UA - Ucraina 5
CI - Costa d'Avorio 4
DE - Germania 4
HK - Hong Kong 2
BE - Belgio 1
ES - Italia 1
IN - India 1
TH - Thailandia 1
Totale 553
Città #
Chandler 67
Singapore 55
Amsterdam 34
Beijing 24
Millbury 17
Santa Clara 17
Princeton 14
Woodbridge 11
Nanjing 10
Naples 10
Boston 8
Jacksonville 8
Ottawa 8
Wilmington 8
Des Moines 6
Hebei 6
Sciacca 4
Ashburn 3
Nanchang 3
Napoli 3
Boardman 2
Changchun 2
Eindhoven 2
Hong Kong 2
Kronberg 2
Lawrence 2
Milan 2
Shenyang 2
Amalfi 1
Atlanta 1
Avezzano 1
Bangkok 1
Belfast 1
Brussels 1
Dallas 1
Fremont 1
Guangzhou 1
Hangzhou 1
Huesca 1
Indiana 1
Jiaxing 1
Redmond 1
Rome 1
Seattle 1
Tianjin 1
Totale 349
Nome #
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 53
A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues 46
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 41
Predictors of non-persistence on statin treatments in Italy: a retrospective cohort study in primary care. 41
Influence of generic drugs on proton pump inhibitor prescription in primary care. 40
La gestione della malattia acido correlata nella medicina di primo livello. Sinergie di utilizzo degli archivi informatizzati per l’informatizzati per l’informazione e la formazione e la formazione professione. 37
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-basad cohort study in Italy. 35
Proton pump inhibitors prescribing following the introduction of generic drugs 34
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin 33
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 31
Proton pump inhibitors market in primary care setting. 31
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study. 30
Predictors of opioid prescribing for non-malignant low back pain in an italian primary care setting 30
Imaging tests in staging and surveillance of early breast cancer in Italy. changes in routine clinical practice and costs implications 27
A hypothetical road map to reduce acid related diseases costs management 26
Prevalence and Characterization of Potential PPI-Clopidogrel Interaction in a Prescription Database in 2006-2009 25
Rifaximin Use, Adherence and Persistence in Patients with Hepatic Encephalopathy: A Real-World Study in the South of Italy 10
Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy 9
Totale 579
Categoria #
all - tutte 3.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.005


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 1 0 0 0 0 16 15 8
2020/202122 0 1 4 2 1 5 1 2 1 0 1 4
2021/2022128 0 1 3 0 3 10 0 5 20 14 37 35
2022/2023172 17 5 2 5 20 27 0 17 25 39 13 2
2023/202466 1 13 11 1 3 2 1 12 1 0 17 4
2024/202579 22 27 2 1 27 0 0 0 0 0 0 0
Totale 579